Literature DB >> 15704653

Expression of Fas receptor on peripheral blood lymphocytes from patients with non-small cell lung cancer.

Grazyna Hoser1, Danuta Wasilewska, Joanna Domagała-Kulawik.   

Abstract

In recent years many data indicate that lymphocytes from cancer patients undergo increased apoptosis. The objective of this study was to evaluate the expression of Fas receptor on lymphocytes obtained from patients with lung cancer. Eighteen patients with non-small cell lung cancer and 18 healthy volunteers were investigated. Expression of Fas (CD95) on CD4+ and CD8+ blood lymphocytes was evaluated by flow cytometry. The proportion of blood Fas+ lymphocytes was significantly higher in lung cancer patients when compared with healthy individuals and in smokers when compared with nonsmokers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15704653

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  5 in total

Review 1.  The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Authors:  Joanna Domagala-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2015-04

2.  How to evaluate the immune status of lung cancer patients before immunotherapy.

Authors:  Joanna Domagala-Kulawik; Agata Raniszewska
Journal:  Breathe (Sheff)       Date:  2017-12

3.  Fas-positive lymphocytes are associated with systemic inflammation in obstructive sleep apnea syndrome.

Authors:  Joanna Domagała-Kulawik; Iwona Kwiecień; Piotr Bielicki; Tomasz Skirecki
Journal:  Sleep Breath       Date:  2018-08-31       Impact factor: 2.816

Review 4.  Lung Cancer in the Course of COPD-Emerging Problems Today.

Authors:  Robert Uliński; Iwona Kwiecień; Joanna Domagała-Kulawik
Journal:  Cancers (Basel)       Date:  2022-08-06       Impact factor: 6.575

Review 5.  Correlation Between Smoking and Passive Smoking with Multiple Sclerosis and the Underlying Molecular Mechanisms.

Authors:  Zhaowei Wang; Jianpin Xie; Chenglong Wu; Guirong Xiao
Journal:  Med Sci Monit       Date:  2019-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.